A Clinical Study to evaluate efficacy of Unani Formulation in Benign Prostatic Hyperplasia
Phase 2
Completed
- Conditions
- Health Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptoms
- Registration Number
- CTRI/2023/09/057510
- Lead Sponsor
- Ayurvedic and Unani Tibbia College Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 40
Inclusion Criteria
Daignosed cases of Benign Prostatic Hyperplasia on digital rectal examination and USG, Volume of prostate 30-60ml,International Prostate symptoms score(IPSS)1-19, PSA less than 4ng/ml, Patient unwilling to sign the consent form.
Exclusion Criteria
Bladder stones , Stricture Urethra, Renal & Hepatic Failure Malignancy, Patient unwilling to sign the consent form.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method volume & weight of prostate gland, postvoid residual urine volumeTimepoint: volume & weight of prostate gland, postvoid residual urine volume
- Secondary Outcome Measures
Name Time Method straining, urgency , hesitency, incomplete emptying,frequency, weak stream,nocturia & <br/ ><br> quality of life of the patient will be assesedTimepoint: 12 weeks